PRA Health Sciences Expands Operations in Singapore
PRA Health Sciences has announced that it is relocating to a new office in Singapore to support its expanded operations in the region.
The move will allow PRA to consolidate its workforce and be strategically located near many of its clients in the area. The new office location is 21 Biopolis Road, Nucleos, Singapore.
“We are excited about this new location,” said Jonathan Newton, PRA Regional Senior Director, Clinical Operations (Asia Pac). “Singapore is an excellent center for clinical research and is the regional hub for PRA in Asia Pacific. This move is recognition of PRA’s commitment to meeting the growing needs of our clients and providing high-quality services in the region.”
Since 2000, PRA has been strategically expanding its Asia Pacific capabilities. In the past two years the Singapore workforce has doubled in size. Since 2010, PRA has conducted 23 clinical trials in Singapore and 3 non-clinical consulting projects.
“We are delighted that PRA values Singapore as a strategic location to coordinate operations in the region, and welcome their decision to invest further here. Their expansion helps to reinforce Singapore’s position as an excellent hub for companies to manage clinical trials across the Asia Pacific region, and as a clinical research location for early phase studies,” said Mr. Kevin Lai, Executive Director, Biomedical Sciences and Consumer Businesses, Singapore Economic Development Board (EDB).
As the Secretariat for the APEC Coordinating Centre for Good Clinical Practice (GCP), Singapore plays a strategic role in developing GCP in Asia, steering initiatives such as the training of clinical research personnel and developing a conducive environment for multi-site clinical trials in the region.